30
Participants
Start Date
May 1, 2016
Primary Completion Date
June 15, 2018
Study Completion Date
June 15, 2018
Xenon129 MRI imaging
subjects will receive at baseline and 3 month post Advair intervention (See next intervention)
Gadolinium MRI
subjects will receive at baseline and 3 month post Advair intervention (See next intervention)
Advair (250mcg/50mcg) one puff twice a day
subjects will receive for 3 month duration between baseline and 3 month post Xenon129 MRI imaging and Gadolinium MRI.
University of Virginia, Charlottesville
National Institutes of Health (NIH)
NIH
University of Virginia
OTHER